Gabriel Loor, MD

Dr. Loor’s mission is to provide hope and cures for patients with advanced heart and lung disease through clinical excellence, research, leadership and education. Through his training and experience he has gained significant expertise in routine and complex adult cardiac surgery and is committed to quality improvement and best practices to make a positive difference in patients’ lives.

Show full bio

Dr. Loor is passionate about maximizing donor organs for lung transplant recipients given the high mortality of patients on the waitlist and a shortage of donor organs. He has successfully initiated portable ex vivo lung perfusion (EVLP) research and clinical programs and is credited with the first “breathing lung” transplant in the Midwest and in Texas.

Dr. Loor received his cardiac surgical and transplant training at Cleveland Clinic, after which he spent several years at the University of Minnesota as assistant professor in cardiac surgery, surgical director of the lung transplant program, co-director of the aortic program and co-director of the adult congenital program. There he significantly increased the volume and quality of lung transplantation through donor utilization and launched the acute aortic emergency program.

Presently, as surgical director of the lung transplant program at Baylor College of Medicine, Dr. Loor’s goal is to lead the world’s largest and highest quality lung transplant program. He also offers and supports the highest standards of clinical excellence and quality in cardiac surgery. Dr. Loor specializes in both routine and complex adult cardiac surgery as well as surgery for advanced heart and lung failure. He also participates in the interventional program for mitral valve and aortic valve disease where minimally invasive techniques are used to avoid open surgery. Dr. Loor’s research interests focus on improving donor utilization and surgical outcomes through basic and translational science collaborations and participation in outcomes registries and clinical trials. Dr. Loor chairs the Cardiovascular Quality Initiative group at Baylor St. Luke’s which seeks to optimize patient outcomes through multidisciplinary collaboration.

See Publications

Education

  • Undergraduate:

    University of Miami (Biochemistry)

  • Medical School:

    Northwestern University, Feinberg School of Medicine

  • Internship:

    University of Chicago Hospitals

  • Residency:

    University of Chicago Hospitals
    Cleveland Clinic

  • Fellowships:

    University of Chicago Hospitals

Academic & Clinical Affiliations

Certifications

  • American Board of Thoracic Surgery
  • American Board of Surgery

Publications

4862227 GNSKWJNU 1 alternatives-to-animal-experimentation 10 date desc Loor 1983 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22RH63ZSY8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ali%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAli%2C%20A.%2C%20Gray%2C%20Z.%2C%20%26lt%3Bstrong%26gt%3BLoor%26lt%3B%5C%2Fstrong%26gt%3B%2C%20G.%20et%20al.%20%282024%29.%20Minimally%20Invasive%20Mitral%20Valve%20Surgery%20Using%20a%20Cold%20Fibrillatory%20Cardiac%20Arrest%20Technique%20in%20Patients%20With%20Prior%20Cardiac%20Surgery.%20%26lt%3Bi%26gt%3BTexas%20Heart%20Institute%20Journal%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%20e238167.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8167%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Minimally%20Invasive%20Mitral%20Valve%20Surgery%20Using%20a%20Cold%20Fibrillatory%20Cardiac%20Arrest%20Technique%20in%20Patients%20With%20Prior%20Cardiac%20Surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20E.%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20K.%22%2C%22lastName%22%3A%22Liao%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Objective%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Minimally%20invasive%20mitral%20valve%20surgery%20%28mini-MVS%29%20is%20typically%20reserved%20for%20patients%20who%20have%20not%20undergone%20open%20cardiac%20surgery.%20In%20the%20reoperative%20setting%2C%20using%20intrapericardial%20dissection%20for%20crossclamping%20the%20aorta%20through%20a%20minimally%20invasive%20approach%20can%20be%20difficult%20and%2C%20at%20times%2C%20risky.%20Cold%20fibrillatory%20cardiac%20arrest%20%28CFCA%29%20with%20systemic%20cardiopulmonary%20bypass%20without%20cross-clamping%20is%20a%20well-described%20technique%3B%20however%2C%20data%20about%20its%20safety%20for%20patients%20who%20undergo%20reoperative%20mini-MVS%20are%20limited.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Data%20for%2034%20patients%20who%20underwent%20reoperative%20mini-MVS%20with%20CFCA%20from%20March%202017%20to%20March%202022%20were%20reviewed%20retrospectively.%20A%20mini%20right%20thoracotomy%20%28n%20%3D%2030%29%20or%20robotic%20%28n%20%3D%204%29%20approach%20was%20used.%20Systemic%20hypothermia%20was%20induced%20to%20a%20target%20temperature%20of%2025%20%5Cu00b0C.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Patient%20mean%20%28SD%29%20age%20was%2064.5%20%289.6%29%20years%2C%20and%2015%20of%2034%20%2844.1%25%29%20patients%20were%20women.%20Of%20those%2034%20patients%2C%2023%20%2867.6%25%29%20had%20severe%20regurgitation%2C%20and%2011%20%2832.4%25%29%20had%20severe%20stenosis.%20Before%20mini-MVS%2C%2028%20patients%20had%20undergone%20valve%20surgery%2C%20and%208%20had%20undergone%20coronary%20artery%20bypass%20graft%20surgery.%20The%20mitral%20valve%20was%20repaired%20in%205%20of%2034%20%2814.7%25%29%20and%20replaced%20in%2029%20of%2034%20%2885.3%25%29%20patients.%20No%20difference%20was%20observed%20in%20preoperative%20and%20postoperative%20left%20ventricular%20function%20%28%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3D%20.82%29.%20In%201%20patient%2C%20kidney%20failure%20developed%20that%20necessitated%20dialysis.%20No%20postoperative%20stroke%20or%20mortality%20at%2030%20days%20occurred.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mini-MVS%20with%20CFCA%20is%20well%20tolerated%20in%20patients%20with%20prior%20cardiac%20surgery.%20Myocardial%20function%20was%20not%20impaired%2C%20nor%20was%20the%20risk%20of%20stroke%20increased%20in%20this%20cohort%2C%20indicating%20that%20CFCA%20is%20a%20safe%20alternative%20in%20this%20high-risk%20population.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-23-8167%22%2C%22ISSN%22%3A%221526-6702%2C%200730-2347%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fthij.kglmeridian.com%5C%2Fview%5C%2Fjournals%5C%2Fthij%5C%2F51%5C%2F2%5C%2Farticle-e238167.xml%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%5D%2C%22dateModified%22%3A%222025-02-06T23%3A12%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22RVHYGRST%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Subramaniam%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSubramaniam%2C%20K.%2C%20%26lt%3Bstrong%26gt%3BLoor%26lt%3B%5C%2Fstrong%26gt%3B%2C%20G.%2C%20Chan%2C%20E.%20G.%20et%20al.%20%282023%29.%20Intraoperative%20red%20blood%20cell%20transfusion%20and%20primary%20graft%20dysfunction%20after%20lung%20transplantation.%20%26lt%3Bi%26gt%3BTransplantation%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FTP.0000000000004545%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FTP.0000000000004545%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Intraoperative%20red%20blood%20cell%20transfusion%20and%20primary%20graft%20dysfunction%20after%20lung%20transplantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathirvel%22%2C%22lastName%22%3A%22Subramaniam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%20G.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brandi%20A.%22%2C%22lastName%22%3A%22Bottiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Ius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Hartwig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daoud%22%2C%22lastName%22%3A%22Daoud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauricio%20A.%22%2C%22lastName%22%3A%22Villavicencio-Theoduloz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asishana%20A.%22%2C%22lastName%22%3A%22Osho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satish%22%2C%22lastName%22%3A%22Chandrashekaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiago%22%2C%22lastName%22%3A%22Noguchi%20Machuca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Van%20Raemdonck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arne%22%2C%22lastName%22%3A%22Neyrinck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshiya%22%2C%22lastName%22%3A%22Toyoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%20A.%22%2C%22lastName%22%3A%22Kashem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Huddleston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20R.%22%2C%22lastName%22%3A%22Ryssel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20G.%22%2C%22lastName%22%3A%22Sanchez%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%20this%20international%2C%20multicenter%20study%20of%20patients%20undergoing%20lung%20transplantation%20%28LT%29%2C%20we%20explored%20the%20association%20between%20the%20amount%20of%20intraoperative%20packed%20red%20blood%20cell%20%28PRBC%29%20transfusion%20and%20occurrence%20of%20primary%20graft%20dysfunction%20%28PGD%29%20and%20associated%20outcomes.%5CnMETHODS%3A%20The%20Extracorporeal%20Life%20Support%20in%20LT%20Registry%20includes%20data%20on%20LT%20recipients%20from%209%20high-volume%20%28%26gt%3B40%20transplants%5C%2Fy%29%20transplant%20centers%20%282%20from%20Europe%2C%207%20from%20the%20United%20States%29.%20Adult%20patients%20who%20underwent%20bilateral%20orthotopic%20lung%20transplant%20from%20January%202016%20to%20January%202020%20were%20included.%20The%20primary%20outcome%20of%20interest%20was%20the%20occurrence%20of%20grade%203%20PGD%20in%20the%20first%2072%5Cu2009h%20after%20LT.%5CnRESULTS%3A%20We%20included%20729%20patients%20who%20underwent%20bilateral%20orthotopic%20lung%20transplant%20between%20January%202016%20and%20November%202020.%20LT%20recipient%20population%20tertiles%20based%20on%20the%20amount%20of%20intraoperative%20PRBC%20transfusion%20%280%2C%201-4%2C%20and%20%26gt%3B4%20units%29%20were%20significantly%20different%20in%20terms%20of%20diagnosis%2C%20age%2C%20gender%2C%20body%20mass%20index%2C%20mean%20pulmonary%20artery%20pressure%2C%20lung%20allocation%20score%2C%20hemoglobin%2C%20prior%20chest%20surgery%2C%20preoperative%20hospitalization%2C%20and%20extracorporeal%20membrane%20oxygenation%20requirement.%20Inverse%20probability%20treatment%20weighting%20logistic%20regression%20showed%20that%20intraoperative%20PRBC%20transfusion%20of%20%26gt%3B4%20units%20was%20significantly%20%28P%5Cu2009%26lt%3B%5Cu20090.001%29%20associated%20with%20grade%203%20PGD%20within%2072%5Cu2009h%20%28odds%20ratio%20%5B95%25%20confidence%20interval%5D%2C%202.2%20%5B1.6-3.1%5D%29.%20Inverse%20probability%20treatment%20weighting%20analysis%20excluding%20patients%20with%20extracorporeal%20membrane%20oxygenation%20support%20produced%20similar%20findings%20%28odds%20ratio%20%5B95%25%20confidence%20interval%5D%2C%202.4%20%5B1.7-3.4%5D%2C%20P%5Cu2009%26lt%3B%5Cu20090.001%29.%5CnCONCLUSIONS%3A%20In%20this%20multicenter%2C%20international%20registry%20study%20of%20LT%20patients%2C%20intraoperative%20transfusion%20of%20%26gt%3B4%20units%20of%20PRBCs%20was%20associated%20with%20an%20increased%20risk%20of%20grade%203%20PGD%20within%2072%5Cu2009h.%20Efforts%20to%20improve%20post-LT%20outcomes%20should%20include%20perioperative%20blood%20conservation%20measures.%22%2C%22date%22%3A%222023-03-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FTP.0000000000004545%22%2C%22ISSN%22%3A%221534-6080%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%225WVJH2TN%22%5D%2C%22dateModified%22%3A%222023-06-08T14%3A40%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22F2QJAXW8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sawinski%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSawinski%2C%20D.%2C%20Lai%2C%20J.%20C.%2C%20Pinney%2C%20S.%20et%20al.%20%282023%29.%20Addressing%20sex-based%20disparities%20in%20solid%20organ%20transplantation%20in%20the%20United%20States%20-%20a%20conference%20report.%20%26lt%3Bi%26gt%3BAm%20J%20Transplant%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%20316%26%23x2013%3B325.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ajt.2022.11.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ajt.2022.11.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Addressing%20sex-based%20disparities%20in%20solid%20organ%20transplantation%20in%20the%20United%20States%20-%20a%20conference%20report%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deirdre%22%2C%22lastName%22%3A%22Sawinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20C.%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Pinney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20L.%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20M.%22%2C%22lastName%22%3A%22Jackson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20Jo%22%2C%22lastName%22%3A%22Levine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayme%20E.%22%2C%22lastName%22%3A%22Locke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Pomposelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Hartwig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shelley%20A.%22%2C%22lastName%22%3A%22Hall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darshana%20M.%22%2C%22lastName%22%3A%22Dadhania%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Cogswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20V.%22%2C%22lastName%22%3A%22Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20D.%22%2C%22lastName%22%3A%22Schold%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20A.%22%2C%22lastName%22%3A%22Turgeon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%22%2C%22lastName%22%3A%22Kobashigawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jasleen%22%2C%22lastName%22%3A%22Kukreja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20C.%22%2C%22lastName%22%3A%22Magee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Friedewald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20S.%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20K.%22%2C%22lastName%22%3A%22Heimbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20C.%22%2C%22lastName%22%3A%22Verna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20Norine%22%2C%22lastName%22%3A%22Walsh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norah%22%2C%22lastName%22%3A%22Terrault%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guiliano%22%2C%22lastName%22%3A%22Testa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Diamond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20P.%22%2C%22lastName%22%3A%22Reese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Orloff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryjane%20A.%22%2C%22lastName%22%3A%22Farr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%20M.%22%2C%22lastName%22%3A%22Olthoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Siegler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Ascher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandy%22%2C%22lastName%22%3A%22Feng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%22%2C%22lastName%22%3A%22Kaplan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Pomfret%22%7D%5D%2C%22abstractNote%22%3A%22Solid%20organ%20transplantation%20provides%20the%20best%20treatment%20for%20end-stage%20organ%20failure%2C%20but%20significant%20sex-based%20disparities%20in%20transplant%20access%20exist.%20On%20June%2025%2C%202021%2C%20a%20virtual%20multidisciplinary%20conference%20was%20convened%20to%20address%20sex-based%20disparities%20in%20transplantation.%20Common%20themes%20contributing%20to%20sex-based%20disparities%20were%20noted%20across%20kidney%2C%20liver%2C%20heart%2C%20and%20lung%20transplantation%2C%20specifically%20the%20existence%20of%20barriers%20to%20referral%20and%20wait%20listing%20for%20women%2C%20the%20pitfalls%20of%20using%20serum%20creatinine%2C%20the%20issue%20of%20donor%5C%2Frecipient%20size%20mismatch%2C%20approaches%20to%20frailty%20and%20a%20higher%20prevalence%20of%20allosensitization%20among%20women.%20In%20addition%2C%20actionable%20solutions%20to%20improve%20access%20to%20transplantation%20were%20identified%2C%20including%20alterations%20to%20the%20current%20allocation%20system%2C%20surgical%20interventions%20on%20donor%20organs%2C%20and%20the%20incorporation%20of%20objective%20frailty%20metrics%20into%20the%20evaluation%20process.%20Key%20knowledge%20gaps%20and%20high-priority%20areas%20for%20future%20investigation%20were%20also%20discussed.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajt.2022.11.008%22%2C%22ISSN%22%3A%221600-6143%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T13%3A52%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22NIQV76E3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chacon-Alberty%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChacon-Alberty%2C%20L.%2C%20Fernandez%2C%20R.%2C%20Jindra%2C%20P.%20et%20al.%20%282023%29.%20Primary%20graft%20dysfunction%20in%20lung%20transplantation%3A%20a%20review%20of%20mechanisms%20and%20future%20applications.%20%26lt%3Bi%26gt%3BTransplantation%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FTP.0000000000004503%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FTP.0000000000004503%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Primary%20graft%20dysfunction%20in%20lung%20transplantation%3A%20a%20review%20of%20mechanisms%20and%20future%20applications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Chacon-Alberty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramiro%22%2C%22lastName%22%3A%22Fernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Jindra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madelyn%22%2C%22lastName%22%3A%22King%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Rosas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camila%22%2C%22lastName%22%3A%22Hochman-Mendez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%5D%2C%22abstractNote%22%3A%22Lung%20allograft%20recipients%20have%20worse%20survival%20than%20all%20other%20solid%20organ%20transplant%20recipients%2C%20largely%20because%20of%20primary%20graft%20dysfunction%20%28PGD%29%2C%20a%20major%20form%20of%20acute%20lung%20injury%20affecting%20a%20third%20of%20lung%20recipients%20within%20the%20first%2072%20h%20after%20transplant.%20PGD%20is%20the%20clinical%20manifestation%20of%20ischemia-reperfusion%20injury%20and%20represents%20the%20predominate%20cause%20of%20early%20morbidity%20and%20mortality.%20Despite%20PGD%26%23039%3Bs%20impact%20on%20lung%20transplant%20outcomes%2C%20no%20targeted%20therapies%20are%20currently%20available%3B%20hence%2C%20care%20remains%20supportive%20and%20largely%20ineffective.%20This%20review%20focuses%20on%20molecular%20and%20innate%20immune%20mechanisms%20of%20ischemia-reperfusion%20injury%20leading%20to%20PGD.%20We%20also%20discuss%20novel%20research%20aimed%20at%20discovering%20biomarkers%20that%20could%20better%20predict%20PGD%20and%20potential%20targeted%20interventions%20that%20may%20improve%20outcomes%20in%20lung%20transplantation.%22%2C%22date%22%3A%22Jan%2017%2C%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FTP.0000000000004503%22%2C%22ISSN%22%3A%221534-6080%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22MJL5PY3A%22%2C%22UDYH8SFB%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A35%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22KYIG8JJX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sylvester%20et%20al.%22%2C%22parsedDate%22%3A%222022-12-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSylvester%2C%20C.%20B.%2C%20Patel%2C%20V.%2C%20Ghanta%2C%20R.%20K.%20et%20al.%20%282022%29.%20Considerations%20for%20left%20atrial%20appendage%20occlusion%20during%20cardiac%20surgery.%20%26lt%3Bi%26gt%3BCardiovasc%20Drugs%20Ther%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10557-022-07415-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10557-022-07415-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Considerations%20for%20left%20atrial%20appendage%20occlusion%20during%20cardiac%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20B.%22%2C%22lastName%22%3A%22Sylvester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20K.%22%2C%22lastName%22%3A%22Ghanta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%5D%2C%22abstractNote%22%3A%22Atrial%20fibrillation%20is%20associated%20with%20an%20increased%20risk%20of%20stroke%20secondary%20to%20thrombus%20formation%20in%20the%20left%20atrial%20appendage.%20Left%20atrial%20appendage%20occlusion%20%28LAAO%29%20is%20an%20effective%20method%20of%20reducing%20the%20risk%20of%20stroke%20in%20patients%20with%20atrial%20fibrillation.%20Although%20LAAO%20does%20not%20remove%20the%20requirement%20for%20anticoagulation%2C%20it%20reduces%20the%20risk%20of%20stroke%20when%20compared%20to%20anticoagulation%20alone.%20We%20critically%20analyze%20the%20data%20on%20LAAO%20in%20cardiac%20surgery.%20We%20also%20discuss%20the%20methods%20of%20LAAO%2C%20the%20risks%20of%20LAAO%2C%20and%20patient%20populations%20that%20could%20benefit%20from%20LAAO.%20We%20discuss%20high-level%20evidence%20that%20LAAO%20at%20the%20time%20of%20cardiac%20surgery%20reduces%20the%20risk%20of%20stroke%20in%20patients%20with%20a%20history%20of%20atrial%20fibrillation.%20In%20patients%20without%20a%20history%20of%20atrial%20fibrillation%20undergoing%20cardiac%20surgery%2C%20we%20suggest%20that%20LAAO%20should%20be%20considered%20in%20select%20patients%20at%20high%20risk%20of%20atrial%20fibrillation%20and%20stroke%2C%20when%20technically%20feasible.%22%2C%22date%22%3A%22Dec%2023%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10557-022-07415-y%22%2C%22ISSN%22%3A%221573-7241%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22AFDZBLNB%22%2C%22UWTRFEPH%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A13%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22I5VKAQ3D%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letsou%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLetsou%2C%20G.%20V.%2C%20Musfee%2C%20F.%20I.%2C%20Zhang%2C%20Q.%20et%20al.%20%282022%29.%20Stroke%20and%20mortality%20rates%20after%20off-pump%20vs.%20pump-assisted%5C%2Fno-clamp%20coronary%20artery%20bypass%20grafting.%20%26lt%3Bi%26gt%3BJ%20Cardiovasc%20Surg%20%28Torino%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%20742%26%23x2013%3B748.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.23736%5C%2FS0021-9509.22.12337-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.23736%5C%2FS0021-9509.22.12337-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Stroke%20and%20mortality%20rates%20after%20off-pump%20vs.%20pump-assisted%5C%2Fno-clamp%20coronary%20artery%20bypass%20grafting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Letsou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadi%20I.%22%2C%22lastName%22%3A%22Musfee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Lee%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Ascending%20aorta%20manipulation%20during%20on-pump%20coronary%20artery%20bypass%20grafting%20%28CABG%29%20surgery%20can%20release%20embolic%20matter%20and%20may%20cause%20stroke.%20Strategies%20for%20lowering%20the%20stroke%20rate%20associated%20with%20coronary%20artery%20bypass%20grafting%20surgery%20include%20off-pump%20surgery%20without%20cardiopulmonary%20bypass%20and%20pump-assisted%20surgery%20with%20minimal%20aortic%20manipulation%20%28i.e.%2C%20without%20aortic%20cross-clamping%29.%20We%20examined%20whether%20one%20approach%20is%20superior%20to%20the%20other%20in%20reducing%20stroke%20and%20perioperative%20mortality%20rates.%5CnMETHODS%3A%20We%20reviewed%20consecutive%20elective%2C%20urgent%2C%20and%20emergency%20off-pump%5C%2Fno-bypass%20and%20pump-assisted%5C%2Fno-clamp%20coronary%20artery%20bypass%20grafting%20procedures%20performed%20by%20a%20single%20surgeon%20at%20our%20institution%20from%20June%202011%20through%20October%202017.%5CnRESULTS%3A%20Of%20570%20patients%20analyzed%2C%20395%20%2869.3%25%29%20underwent%20off-pump%5C%2Fno-bypass%20surgery%2C%2043%20%287.5%25%29%20underwent%20pump-assisted%5C%2Fno-clamp%20surgery%2C%20and%20132%20%2823.2%25%29%20transitioned%20mid-procedure%20from%20off-pump%5C%2Fno-bypass%20to%20pump-assisted%5C%2Fno-clamp%20surgery.%20Patients%20who%20were%20%26gt%3B70%20years%20old%2C%20were%20female%2C%20or%20had%20diabetes%2C%20cardiomegaly%2C%20or%20a%20history%20of%20myocardial%20infarction%20or%20congestive%20heart%20failure%20were%20more%20likely%20to%20undergo%20pump-assisted%5C%2Fno-clamp%20surgery%20or%20the%20combined%20technique.%20None%20of%20the%20pump-assisted%5C%2Fno-clamp%20patients%20had%20a%20stroke%2C%20versus%200.3%25%20of%20the%20off-pump%5C%2Fno-bypass%20patients%20and%200.8%25%20of%20the%20combination%20patients.%20Stroke%20and%20in-hospital%20mortality%20rates%20did%20not%20differ%20by%20technique.%5CnCONCLUSIONS%3A%20A%20hybrid%20strategy%20incorporating%20off-pump%2C%20pump-assisted%2C%20and%20combined%20off-pump%5C%2Fpump-assisted%20techniques%20achieved%20very%20low%20stroke%20rates%20in%20patients%20undergoing%20coronary%20revascularization.%20Perioperative%20mortality%20was%20similar%20for%20all%20three%20techniques.%20Avoiding%20aortic%20clamping%20may%20be%20crucial%20for%20decreasing%20CABG-related%20stroke%20rates.%20Off-pump%5C%2Fno-bypass%20surgery%20had%20no%20significant%20advantage%20over%20the%20pump-assisted%5C%2Fno-clamp%20or%20combined%20techniques%20in%20reducing%20the%20stroke%20rate%20after%20coronary%20artery%20bypass%20grafting%20surgery.%22%2C%22date%22%3A%22Dec%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.23736%5C%2FS0021-9509.22.12337-2%22%2C%22ISSN%22%3A%221827-191X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YZAQAZIS%22%2C%22GNSKWJNU%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A15%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22K3ZBBBHU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chacon-Alberty%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-29%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChacon-Alberty%2C%20L.%2C%20Ye%2C%20S.%2C%20Elsenousi%2C%20A.%20et%20al.%20%282022%29.%20Effect%20of%20intraoperative%20support%20mode%20on%20circulating%20inflammatory%20biomarkers%20after%20lung%20transplantation%20surgery.%20%26lt%3Bi%26gt%3BArtif%20Organs%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.14474%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Faor.14474%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20intraoperative%20support%20mode%20on%20circulating%20inflammatory%20biomarkers%20after%20lung%20transplantation%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Chacon-Alberty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengbin%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdussalam%22%2C%22lastName%22%3A%22Elsenousi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Hills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madelyn%22%2C%22lastName%22%3A%22King%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22D%27Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andres%20Pena%22%2C%22lastName%22%3A%22Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Salan-Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camila%22%2C%22lastName%22%3A%22Hochman-Mendez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Processes%20that%20activate%20the%20immune%20system%20during%20lung%20transplantation%20can%20lead%20to%20primary%20graft%20dysfunction%20%28PGD%29%20or%20allograft%20rejection.%5CnMETHODS%3A%20We%20analyzed%20cytokine%20expression%20profiles%20after%20reperfusion%20and%20allograft%20outcomes%20in%20a%20cohort%20of%20patients%20%28n%5Cu00a0%3D%5Cu00a059%29%20who%20underwent%20lung%20transplantation%20off-pump%20%28n%5Cu00a0%3D%5Cu00a026%29%2C%20with%20cardiopulmonary%20bypass%20%28CPB%3B%20n%5Cu00a0%3D%5Cu00a018%29%2C%20or%20with%20extracorporeal%20membrane%20oxygenation%20%28ECMO%3B%20n%5Cu00a0%3D%5Cu00a015%29.%20Peripheral%20blood%20was%20collected%20from%20patients%20at%20baseline%20and%20at%206%20and%2072%5Cu00a0h%20after%20reperfusion.%20To%20adjust%20for%20clinical%20differences%20between%20groups%2C%20we%20utilized%20a%20linear%20mixed%20model%20with%20overlap%20weighting.%5CnRESULTS%3A%20PGD3%20was%20present%20at%2048%20or%2072%5Cu00a0h%20after%20reperfusion%20in%207.7%25%20%282%5C%2F26%29%20of%20off-pump%20cases%2C%2020.0%25%20%283%5C%2F15%29%20of%20ECMO%20cases%2C%20and%2038.9%25%20%287%5C%2F18%29%20of%20CPB%20cases%20%28p%5Cu00a0%3D%5Cu00a00.04%29.%20The%20ECMO%20and%20CPB%20groups%20had%20greater%20reperfusion-induced%20increases%20in%20MIP-1B%2C%20IL-6%2C%20IL-8%2C%20IL-9%2C%20IL1-ra%2C%20TNF-alpha%2C%20RANTES%2C%20eotaxin%2C%20IP-10%2C%20and%20MCP-1%20levels%20than%20the%20off-pump%20group.%20Cytokine%20expression%20profiles%20after%20reperfusion%20were%20not%20significantly%20different%20between%20ECMO%20and%20CPB%20groups.%5CnCONCLUSION%3A%20Our%20data%20suggest%20that%2C%20compared%20with%20an%20off-pump%20approach%2C%20the%20intraoperative%20use%20of%20ECMO%20or%20CPB%20during%20lung%20transplantation%20is%20associated%20with%20greater%20reperfusion-induced%20cytokine%20release%20and%20graft%20injury.%22%2C%22date%22%3A%22Nov%2029%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Faor.14474%22%2C%22ISSN%22%3A%221525-1594%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22MJL5PY3A%22%2C%22UDYH8SFB%22%2C%22TXW6RMW4%22%2C%22AZFR6V65%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A13%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22KUR55T7L%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chacon-Alberty%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-27%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChacon-Alberty%2C%20L.%2C%20Kanchi%2C%20R.%20S.%2C%20Ye%2C%20S.%20et%20al.%20%282022%29.%20Plasma%20protein%20biomarkers%20for%20primary%20graft%20dysfunction%20after%20lung%20transplantation%3A%20a%20single-center%20cohort%20analysis.%20%26lt%3Bi%26gt%3BSci%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%2016137.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-20085-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-20085-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Plasma%20protein%20biomarkers%20for%20primary%20graft%20dysfunction%20after%20lung%20transplantation%3A%20a%20single-center%20cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Chacon-Alberty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupa%20S.%22%2C%22lastName%22%3A%22Kanchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengbin%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camila%22%2C%22lastName%22%3A%22Hochman-Mendez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daoud%22%2C%22lastName%22%3A%22Daoud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristian%22%2C%22lastName%22%3A%22Coarfa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20L.%22%2C%22lastName%22%3A%22Grimm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maher%22%2C%22lastName%22%3A%22Baz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Rosas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%5D%2C%22abstractNote%22%3A%22The%20clinical%20use%20of%20circulating%20biomarkers%20for%20primary%20graft%20dysfunction%20%28PGD%29%20after%20lung%20transplantation%20has%20been%20limited.%20In%20a%20prospective%20single-center%20cohort%2C%20we%20examined%20the%20use%20of%20plasma%20protein%20biomarkers%20as%20indicators%20of%20PGD%20severity%20and%20duration%20after%20lung%20transplantation.%20The%20study%20comprised%2040%20consecutive%20lung%20transplant%20patients%20who%20consented%20to%20blood%20sample%20collection%20immediately%20pretransplant%20and%20at%206%2C%2024%2C%2048%2C%20and%2072%5Cu00a0h%20after%20lung%20transplant.%20An%20expert%20grader%20determined%20the%20severity%20and%20duration%20of%20PGD%20and%20scored%20PGD%20at%20T0%20%286%5Cu00a0h%20after%20reperfusion%29%2C%20T24%2C%20T48%2C%20and%20T72%20h%20post-reperfusion%20using%20the%202016%20ISHLT%20consensus%20guidelines.%20A%20bead-based%20multiplex%20assay%20was%20used%20to%20measure%2027%20plasma%20proteins%20including%20cytokines%2C%20growth%20factors%2C%20and%20chemokines.%20Enzyme-linked%20immunoassay%20was%20used%20to%20measure%20cell%20injury%20markers%20including%20M30%2C%20M65%2C%20soluble%20receptor%20of%20advanced%20glycation%20end-products%20%28sRAGE%29%2C%20and%20plasminogen%20activator%20inhibitor-1%20%28PAI-1%29.%20A%20pairwise%20comparisons%20analysis%20was%20used%20to%20assess%20differences%20in%20protein%20levels%20between%20PGD%20severity%20scores%20%281%2C%202%2C%20and%203%29%20at%20T0%2C%20T24%2C%20T48%2C%20and%20T72%20h.%20Sensitivity%20and%20temporal%20analyses%20were%20used%20to%20explore%20the%20association%20of%20protein%20expression%20patterns%20and%20PGD3%20at%20T48-72%5Cu00a0h%20%28the%20most%20severe%2C%20persistent%20form%20of%20PGD%29.%20We%20used%20the%20Benjamini-Hochberg%20method%20to%20adjust%20for%20multiple%20testing.%20Of%20the%2040%20patients%2C%2022%20%2855%25%29%20had%20PGD3%20at%20some%20point%20post-transplant%20from%20T0%20to%20T72%20h%3B%2012%20%2830%25%29%20had%20PGD3%20at%20T48-72%5Cu00a0h.%20In%20the%20pairwise%20comparison%2C%20we%20identified%20a%20robust%20plasma%20protein%20expression%20signature%20for%20PGD%20severity.%20In%20the%20sensitivity%20analysis%2C%20using%20a%20linear%20model%20for%20microarray%20data%2C%20we%20found%20that%20differential%20perioperative%20expression%20of%20IP-10%2C%20MIP1B%2C%20RANTES%2C%20IL-8%2C%20IL-1Ra%2C%20G-CSF%2C%20and%20PDGF-BB%20correlated%20with%20PGD3%20development%20at%20T48-72%5Cu00a0h%20%28FDR%5Cu2009%26lt%3B%5Cu20090.1%20and%20p%5Cu2009%26lt%3B%5Cu20090.05%29.%20In%20the%20temporal%20analysis%2C%20using%20linear%20mixed%20modeling%20with%20overlap%20weighting%2C%20we%20identified%20unique%20protein%20patterns%20in%20patients%20who%20did%20or%20did%20not%20develop%20PGD3%20at%20T48-72%5Cu00a0h.%20Our%20findings%20suggest%20that%20unique%20inflammatory%20protein%20expression%20patterns%20may%20be%20informative%20of%20PGD%20severity%20and%20duration.%20PGD%20biomarker%20panels%20may%20improve%20early%20detection%20of%20PGD%2C%20predict%20its%20clinical%20course%2C%20and%20help%20monitor%20treatment%20efficacy%20in%20the%20current%20era%20of%20lung%20transplantation.%22%2C%22date%22%3A%22Sept%2027%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-022-20085-y%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22MJL5PY3A%22%2C%22UDYH8SFB%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A26%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22HXJ936LZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Richards%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRichards%2C%20K.%2C%20Li%2C%20G.%2C%20Segraves%2C%20J.%20et%20al.%20%282022%29.%20A%2076-year-old%20man%20with%20exertional%20hypoxemia%20after%20left%20single%20lung%20transplantation.%20%26lt%3Bi%26gt%3BAnn%20Am%20Thorac%20Soc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%2C%201591%26%23x2013%3B1595.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1513%5C%2FAnnalsATS.202202-172CC%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1513%5C%2FAnnalsATS.202202-172CC%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%2076-year-old%20man%20with%20exertional%20hypoxemia%20after%20left%20single%20lung%20transplantation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Richards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gloria%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Segraves%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Puneet%22%2C%22lastName%22%3A%22Garcha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anupam%22%2C%22lastName%22%3A%22Kumar%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sept%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1513%5C%2FAnnalsATS.202202-172CC%22%2C%22ISSN%22%3A%222325-6621%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22C27MTI39%22%5D%2C%22dateModified%22%3A%222022-10-05T15%3A40%3A37Z%22%7D%7D%2C%7B%22key%22%3A%223V5UTWLS%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Miggins%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMiggins%2C%20J.%20J.%2C%20Reul%2C%20R.%20M.%2C%20%26lt%3Bstrong%26gt%3BLoor%26lt%3B%5C%2Fstrong%26gt%3B%2C%20G.%20et%20al.%20%282022%29.%20Trends%20in%20marginal%20lung%20allograft%20survival%3A%20Advanced-age%20donors%20improve.%20%26lt%3Bi%26gt%3BClin%20Transplant%26lt%3B%5C%2Fi%26gt%3B%2C%20e14777.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fctr.14777%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fctr.14777%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Trends%20in%20marginal%20lung%20allograft%20survival%3A%20Advanced-age%20donors%20improve%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20James%22%2C%22lastName%22%3A%22Miggins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ross%20Michael%22%2C%22lastName%22%3A%22Reul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%20D.%22%2C%22lastName%22%3A%22Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Puneet%20S.%22%2C%22lastName%22%3A%22Garcha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Goss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abbas%20A.%22%2C%22lastName%22%3A%22Rana%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Although%20lung%20demand%20continues%20to%20outpace%20supply%2C%2075%25%20of%20potential%20donor%20lungs%20are%20discarded%20without%20being%20transplanted%20in%20the%20United%20States.%20To%20identify%20the%20discarded%20cohorts%20best%20suited%20to%20alleviate%20the%20lung%20shortage%20and%20reduce%20waitlist%20mortality%2C%20we%20explored%20changes%20in%20survival%20over%20time%20for%20five%20marginal%20donor%20definitions%3A%20age%5Cu00a0%26gt%3B60%20years%2C%20smoking%20history%5Cu00a0%26gt%3B20%20pack-years%2C%20PaO2%20%5C%2FFiO2%20%5Cu00a0%26lt%3B%5Cu00a0300%5Cu00a0mmHg%2C%20purulent%20bronchoscopic%20secretions%2C%20and%20chest%20radiograph%20infiltrates.%5CnMETHODS%3A%20Our%20retrospective%20cohort%20study%20separated%2027%5Cu00a0803%20lung%20recipients%20in%20the%20UNOS%20Database%20into%20three%205-year%20eras%20by%20transplant%20date%3A%202005-2009%2C%202010-2014%2C%20and%202015-2019.%20Multivariable%20Cox%20proportional%20hazards%20regression%20and%20Kaplan-Meier%20analysis%20with%20log-rank%20test%20were%20used%20to%20compare%20survival%20across%20the%20eras.%5CnRESULTS%3A%20Three%20definitions-low%20PaO2%20%5C%2FFiO2%20%2C%20purulent%20bronchoscopic%20secretions%2C%20and%20abnormal%20chest%20radiographs-did%20not%20bear%20out%20as%20truly%20marginal%2C%20demonstrating%20lack%20of%20significantly%20elevated%20risk.%20Advanced%20donor%20age%20demonstrated%20considerable%20survival%20improvement%20%28HR%20%2895%25%20CI%29%3A%201.47%20%281.26-1.72%29%20in%202005-2009%20down%20to%201.14%20%28.97-1.35%29%20for%202015-2019%29%2C%20with%20protective%20factors%20being%20recipients%20%26lt%3B60%20years%2C%20moderate%20recipient%20BMI%2C%20and%20low%20Lung%20Allocation%20Score%20%28LAS%29.%20Donors%20with%20smoking%20history%20failed%20to%20demonstrate%20any%20significant%20improvement%20%28HR%20%2895%25%20CI%29%3A%201.09%20%281.01-1.17%29%20in%202005-2009%20increasing%20to%201.22%20%281.08-1.38%29%20in%202015-2019%29.%5CnCONCLUSIONS%3A%20Advanced%20donor%20age%2C%20previously%20the%20most%20significant%20risk%20factor%2C%20has%20improved%20to%20near-benchmark%20levels%2C%20demonstrating%20the%20possibility%20for%20matching%20older%20donors%20to%20healthier%20non-elderly%20recipients%20in%20selected%20circumstances.%20Low%20PaO2%20%5C%2FFiO2%20%2C%20bronchoscopic%20secretions%2C%20and%20abnormal%20radiographs%20demonstrated%20survival%20on%20par%20with%20standard%20donors.%20Significant%20donor%20smoking%20history%2C%20a%20moderate%20risk%20factor%2C%20has%20failed%20to%20improve.%22%2C%22date%22%3A%22July%2013%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fctr.14777%22%2C%22ISSN%22%3A%221399-0012%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A43%3A02Z%22%7D%7D%5D%7D
Ali, A., Gray, Z., Loor, G. et al. (2024). Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Texas Heart Institute Journal 51, e238167. https://doi.org/10.14503/THIJ-23-8167.
Subramaniam, K., Loor, G., Chan, E. G. et al. (2023). Intraoperative red blood cell transfusion and primary graft dysfunction after lung transplantation. Transplantation. https://doi.org/10.1097/TP.0000000000004545.
Sawinski, D., Lai, J. C., Pinney, S. et al. (2023). Addressing sex-based disparities in solid organ transplantation in the United States - a conference report. Am J Transplant 23, 316–325. https://doi.org/10.1016/j.ajt.2022.11.008.
Chacon-Alberty, L., Fernandez, R., Jindra, P. et al. (2023). Primary graft dysfunction in lung transplantation: a review of mechanisms and future applications. Transplantation. https://doi.org/10.1097/TP.0000000000004503.
Sylvester, C. B., Patel, V., Ghanta, R. K. et al. (2022). Considerations for left atrial appendage occlusion during cardiac surgery. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-022-07415-y.
Letsou, G. V., Musfee, F. I., Zhang, Q. et al. (2022). Stroke and mortality rates after off-pump vs. pump-assisted/no-clamp coronary artery bypass grafting. J Cardiovasc Surg (Torino) 63, 742–748. https://doi.org/10.23736/S0021-9509.22.12337-2.
Chacon-Alberty, L., Ye, S., Elsenousi, A. et al. (2022). Effect of intraoperative support mode on circulating inflammatory biomarkers after lung transplantation surgery. Artif Organs. https://doi.org/10.1111/aor.14474.
Chacon-Alberty, L., Kanchi, R. S., Ye, S. et al. (2022). Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis. Sci Rep 12, 16137. https://doi.org/10.1038/s41598-022-20085-y.
Richards, K., Li, G., Segraves, J. et al. (2022). A 76-year-old man with exertional hypoxemia after left single lung transplantation. Ann Am Thorac Soc 19, 1591–1595. https://doi.org/10.1513/AnnalsATS.202202-172CC.
Miggins, J. J., Reul, R. M., Loor, G. et al. (2022). Trends in marginal lung allograft survival: Advanced-age donors improve. Clin Transplant, e14777. https://doi.org/10.1111/ctr.14777.

Recent News

Creative Strategies Used to Save COVID Patient Who Needed 149 Days of Extracorporeal Membrane Oxygenation

Infection with COVID-19 can take many forms. It can be mild enough to be mistaken for the common cold, or...

The Texas Heart Institute Journal’s Global Outreach

Since its founding in 1962, The Texas Heart Institute has remained dedicated to improving cardiovascular care worldwide through international collaboration,...

The Texas Heart Institute Makes a Strong Showing at ISHLT 2023

Daniel Timms, PhD, founder and chief technical officer of BiVACOR, Inc., described the benchtop testing and preclinical studies performed with...